Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol closed-loop target-controlled infusion combined with remifentanil at different infusion rates for sedative-analgesic anesthesia
ChiCTR-IPR-17014193Phase 4Not yet recruiting
- Sponsor
- Plastic Surgery Hospital of Chinese Academy of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and remifentanil in None (3 arms), sponsored by Plastic Surgery Hospital of Chinese Academy of Medical Sciences. Primary endpoints: BIS, Pump speed of remifentanil and 4 more. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
propofolremifentanil
Beyond the preview
Go deeper on ChiCTR-IPR-17014193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17014193.